-
Under the Hood with a rare earths’ products manufacturer that is consistently profitable and cashed up
Apparently, my “watchlist” is far too large these days. When I circle around to have a look at…
-
Steve Saviuk on Valeo Pharma’s TSX Listing and Q1-22 revenues of $4.2 million, up 128% over Q1-21
In a recent InvestorIntel interview, Tracy Weslosky interviews Valeo Pharma Inc.’s (TSX: VPH | OTCQB: VPHIF) Founder, CEO…
-
Justin Cochrane on Carbon Streaming’s carbon credit streams and investment pipeline and uplisting to NASDAQ
In a recent InvestorIntel interview, Tracy Weslosky spoke with Justin Cochrane about Carbon Streaming Corporation’s (NEO: NETZ |…
-
Valeo Pharma’s rocketing growth in sales points to positive cash flow this year
Stock market investors love companies that can quickly expand and rapidly grow their revenues. The very best of…
